Director, CDx & Clinical Platform Development
Roche
Summary
As a senior leader within Translational Medicine's Scientific Operations, Diagnostics Development and Technology (TM-ODT) function, the Director of CDx and Clinical Platform Development is responsible for architecting the long-term vision and operational framework across three foundational pillars: Companion Diagnostic (CDx) Development, Clinical Platform Development, and Biomarker Policy Innovation.
Job description
Strategic Vision and Leadership Impact
- Formulate and implement an overarching diagnostic co-development strategy to expedite the progression of the Roche/Genentech therapeutic pipeline from early-stage development through to global regulatory approvals.
- Develop and oversee key strategic partnerships with both internal and external diagnostic collaborators, ensuring clinical platform developments activities align with future clinical and scientific requirements.
- Promote an environment of scientific rigor and forward-looking strategy, developing a robust, top-tier team equipped to handle the intricacies of both standard (such as IHC, PCR, NGS) and emerging (such as advanced liquid biopsy, digital pathology, and multi-omic assays) diagnostic assay and clinical platform development.
- Enhance cross-functional alignment by acting as a primary interface connecting Translational Medicine (TM) with Roche Diagnostics and Foundation Medicine (FMI).
- Cultivate and manage critical strategic alliances with internal and external regulatory and policy collaborators, ensuring the successful translation of biomarker innovations into future policy frameworks.
Communication / Interaction
- Collaborates strategically with VPs/SVP of Translational Medicine, TM Disease Area Leaders (DALs), Translational Medicine Subteam Leaders (TMSTLs), gRED, PD, Regulatory, Commercial, Medical Affairs, Roche Diagnostics, Foundation Medicine, and external collaborators to guide molecule and above-molecule development strategies for CDx development, Clinical Platform development and Biomarker-based Regulatory Policy Innovation.
- Maintains a robust and collaborative partnership with the pRED CDx development group, as well as pRED's biomarker and technology focused functions.
- Connects with external stakeholders, such as regulatory policy consortia, Health Authorities and TAEs in order to drive novel pathways for biomarker innovation at the portfolio and/or disease area level.
Leadership / Management / Supervision
- Manage and mentor a team of 6-8 scientific professionals, assuming full accountability for talent acquisition, retention, and proactive succession planning.
- Define unit priorities, operational blueprints, and internal budgets, ensuring efficient resource deployment across molecular programs and strategic campaigns.
- Foster an inclusive culture of scientific excellence, supporting team members in resolving matrixed challenges and optimizing complex priority workflows.
Teamwork and Interaction
- Drives a high-performing, collaborative team culture while actively encouraging cross-functional knowledge sharing and alignment.
- Establishes robust, trust-driven alliances across multi-functional groups including Clinical Science, Commercial, Regulatory, Medical Affairs, Clinical Operations, Biomarker Operations, TM, Roche Diagnostics, and Foundation Medicine.
- Collaborates closely with leadership in gRED BOMs and PD BOMs (Biomarker Operations Managers) to bridge clinical platform and diagnostic development with operational execution seamlessly across both early and late-stage programs.
- Navigate enterprise boundaries to cultivate productive engagements with internal and external partners, exerting influence across all organizational levels.
Requirements
- Bachelor of Science (BS) degree in life sciences, biomedical engineering, or a related bioscience field
- 12-15 years of professional experience within biotech, pharma, or diagnostics sectors
- 5+ years of experience in CDx or IVD development
- 3+ years of people leadership experience overseeing scientific professionals in a matrixed corporate environment
- Deep understanding of CDx, IVD, and clinical platform development covering assay design, analytical/clinical validation, bridging approaches, and regulatory pathways such as FDA PMA/IDE, EMA IVDR, and China NMPA
- Extensive familiarity with established and emerging clinical platforms including IHC, PCR, NGS, liquid biopsy, digital pathology, multi-omic assays
- Thorough grasp of the drug development lifecycle including clinical trial designs and endpoints
- Knowledge of external regulatory policy including consortium leadership, public comment procedures, and Health Authority engagement methods
- Demonstrated experience interacting with global Health Authorities (such as FDA and EMA) on IVD/CDx regulatory issues
- Advanced degree preferred
- Prior background in regulatory science, consortia leadership, or external policy influence preferred
- Experience regarding diagnostic product rollouts, market access trends, test reimbursement, and clinical guidelines preferred
Benefits
- Relocation benefits
- Discretionary annual bonus
- Medical, Dental & Vision
- 401(k)
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.